Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ritesh Tichkule

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Expert Opinion on Therapeutic Patents|November 27, 2009
Latest advances in cannabinoid receptor agonistsGanesh A Thakur, Ritesh Tichkule, Shama Bajaj, et al.
Plos One|October 3, 2014
Cannabinoids alleviate experimentally induced intestinal inflammation by acting at central and peripheral receptorsJakub Fichna, Misha Bawa, Ganesh A Thakur, et al.
Behavioural Pharmacology|March 8, 2014
In-vivo pharmacological evaluation of the CB1-receptor allosteric modulator Org-27569Thomas F Gamage, Bogna M Ignatowska-Jankowska, Jenny L Wiley, et al.
Bioorganic & Medicinal Chemistry|July 5, 2011
Human HDAC isoform selectivity achieved via exploitation of the acetate release channel with structurally unique small molecule inhibitorsLewis Whitehead, Markus R Dobler, Branko Radetich, et al.
Journal of Medicinal Chemistry|December 8, 2025
Harnessing Glutamine-117 Plasticity toward Structure-Based Identification of Triazole IL-17 InhibitorsMatthias R Bauer, Juraj Velcicky, Alban Goetz, et al.
Nature Chemical Biology|June 19, 2019
A small-molecule inhibitor of C5 complement proteinKeith Jendza, Mitsunori Kato, Michael Salcius, et al.
Journal of Medicinal Chemistry|January 29, 2019
6-Amino-3-methylpyrimidinones as Potent, Selective, and Orally Efficacious SHP2 InhibitorsPatrick Sarver, Michael Acker, Jeffrey T Bagdanoff, et al.
Journal of Medicinal Chemistry|February 17, 2025
Discovery of GJG057, a Potent and Highly Selective Inhibitor of Leukotriene C4 SynthaseGebhard Thoma, Wolfgang Miltz, Rudolf Waelchli, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Expert Opinion on Therapeutic Patents|November 27, 2009
Latest advances in cannabinoid receptor agonistsGanesh A Thakur, Ritesh Tichkule, Shama Bajaj, et al.
Plos One|October 3, 2014
Cannabinoids alleviate experimentally induced intestinal inflammation by acting at central and peripheral receptorsJakub Fichna, Misha Bawa, Ganesh A Thakur, et al.
Behavioural Pharmacology|March 8, 2014
In-vivo pharmacological evaluation of the CB1-receptor allosteric modulator Org-27569Thomas F Gamage, Bogna M Ignatowska-Jankowska, Jenny L Wiley, et al.
Bioorganic & Medicinal Chemistry|July 5, 2011
Human HDAC isoform selectivity achieved via exploitation of the acetate release channel with structurally unique small molecule inhibitorsLewis Whitehead, Markus R Dobler, Branko Radetich, et al.
Journal of Medicinal Chemistry|December 8, 2025
Harnessing Glutamine-117 Plasticity toward Structure-Based Identification of Triazole IL-17 InhibitorsMatthias R Bauer, Juraj Velcicky, Alban Goetz, et al.
Nature Chemical Biology|June 19, 2019
A small-molecule inhibitor of C5 complement proteinKeith Jendza, Mitsunori Kato, Michael Salcius, et al.
Journal of Medicinal Chemistry|January 29, 2019
6-Amino-3-methylpyrimidinones as Potent, Selective, and Orally Efficacious SHP2 InhibitorsPatrick Sarver, Michael Acker, Jeffrey T Bagdanoff, et al.
Journal of Medicinal Chemistry|February 17, 2025
Discovery of GJG057, a Potent and Highly Selective Inhibitor of Leukotriene C4 SynthaseGebhard Thoma, Wolfgang Miltz, Rudolf Waelchli, et al.
Pageof 1